Skip to main content
Apheris

AI Tech Lead: Large Molecules

RemoteGermany onlyArchived
Published
Role
AI / ML
Experience
Senior
Employment
Full-time
Salary not disclosed
Check eligibility

Open to DE only. Set where you work from to check your eligibility.

No BS summary

Technical lead for large molecule AI model programs, focusing on foundation models, structural biology, protein engineering, and federated learning. You will lead teams building and operationalizing ML systems for antibody modeling, co-folding, and developability prediction, turning scientific goals into reliable model systems. Requires 5+ years applying ML to biological problems, Python/PyTorch experience with large models (OpenFold, ESM), and MLOps/Kubernetes experience.

Core skills

foundation modelsstructural biologyfederated learning

Required skills

PythonPyTorchKubernetes

Optional skills

privacy-preserving MLdistributed trainingmulti-party training environmentsproduction-grade model delivery in regulated, enterprise, pharmaceutical, biotech, or other high-trust environmentspublication record in top-tier ML, computational biology, or structural biology venues

What you'll do

  • Lead teams building and delivering federated large molecule AI systems, staying hands-on across antibody modeling, co-folding, binder prediction, and developability.
  • Build and implement ML applications large bio molecular foundation models such as OpenFold, Boltz-2 and ESM.
  • Own delivery of these against committed milestones and ensure high-quality model releases ship on time.
  • Translate ambiguous scientific and technical goals into clear plans, priorities, work streams, and decisions.
  • Guide evaluation decisions and build on them to deliver results packages to external stakeholders.
  • Surface risks, blockers, bugs, timeline changes, and technical trade-offs early, with clear recommendations.
  • Align consortium members on objectives, evaluation criteria, data requirements, timelines, and delivery expectations.
  • Work with product, engineering, research, and leadership to ensure application requirements shape the model roadmap.

What they require

  • PhD, MSc, or equivalent experience in a relevant field, plus 5+ years applying ML to complex scientific or biological problems, ideally in structural biology, antibody engineering, biologics discovery, developability prediction, binder prediction or protein design.
  • You have MLOps or ML infrastructure experience, particularly with Kubernetes-based training, evaluation, or deployment workflows.
  • You can define success criteria, validate model quality, and ensure ML releases are robust enough for real-world use.
  • You have led delivery of complex ML projects, including setting technical direction, managing risks and dependencies, and driving teams toward high-quality releases.
  • You are comfortable operating as a player-coach: mentoring engineers and ML scientists while contributing directly to modeling, experimentation, or architecture when needed.
  • You can work effectively with product, research, leadership, customers, and scientific stakeholders to turn ambiguous requirements into clear technical plans.

Benefits

  • Industry-competitive compensation, including early-stage virtual share options
  • Remote-first working – work where you work best
  • Wellbeing budget, mental health support, work-from-home budget, co-working stipend, and learning budget
  • Generous holiday allowance
  • Office Days at our Berlin HQ or a different European location (3x per year)

At Apheris, we are building the future of how AI is applied in pharmaceutical R&D. We enable leading pharmaceutical teams to discover and develop drugs faster. We host the industry’s largest federated data networks for drug discovery AI, spanning co-folding, ADMET, and antibody developability. Across these networks, models are trained on proprietary industry datasets to achieve higher performance and broader applicability while keeping data control and IP protected. We deliver these superior models through drug discovery applications that enable teams to run them at scale, further customize them, and integrate them into existing R&D workflows. AI Structural Biology (AISB) Network: Pharmaceutical companies collaborate in the field of co-folding, structure-based binding affinity predictions and antibody design.ADMET Network: Pharmaceutical and biotech companies collaborate to improve small-molecule property prediction and expand into further drug modalities.Antibody developability Network:Pharma partners collaborate to federate historical and purpose-built antibody developability data sets for secure ML training, without data leaving each partner’s environment.

BiotechStartupapheris.com/
Salary not disclosed